Europe Vaccine Adjuvants Market Size & Outlook, 2026-2033
Related Markets
Europe vaccine adjuvants market highlights
- The Europe vaccine adjuvants market generated a revenue of USD 1,044.1 million in 2025.
- The market is expected to grow at a CAGR of 5.3% from 2026 to 2033.
- In terms of segment, particulate was the largest revenue generating type in 2025.
- Pathogen is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 1,044.1 million |
| Market revenue in 2033 | USD 1,547.8 million |
| Growth rate | 5.3% (CAGR from 2026 to 2033) |
| Largest segment | Particulate |
| Fastest growing segment | Pathogen |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pathogen, Adjuvant Emulsion, Particulate, Combination adjuvants |
| Key market players worldwide | GlaxoSmithKline, Novavax Inc, Adjuvance Technologies, Associated British Foods PLC, CSL Ltd, InvivoGen, Agenus Inc, Brenntag Biosector |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.5% of the global vaccine adjuvants market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,472.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Vaccine Adjuvants Market Scope
Vaccine Adjuvants Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Brenntag Biosector | View profile | - | Ballerup, Hovedstaden, Denmark, Europe | - |
| Agenus Inc | View profile | 389 | 3 Forbes Road, Lexington, MA, United States, 02421 | https://www.agenusbio.com |
| Adjuvance Technologies | View profile | 11-50 | Lincoln, Nebraska, United States, North America | http://adjuvancetechnologies.com/ |
| Novavax Inc | View profile | 1992 | 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878 | https://www.novavax.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| InvivoGen | View profile | 101-250 | Toulouse, Midi-Pyrenees, France, Europe | http://invivogen.com |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Associated British Foods PLC | View profile | 133000 | 10 Grosvenor Street, Weston Centre, London, United Kingdom, W1K 4QY | https://www.abf.co.uk |
Europe vaccine adjuvants market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine adjuvants market will help companies and investors design strategic landscapes.
Particulate was the largest segment with a revenue share of 30.4% in 2025. Horizon Databook has segmented the Europe vaccine adjuvants market based on pathogen, adjuvant emulsion, particulate, combination adjuvants covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Europe vaccine adjuvants market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe vaccine adjuvants market databook
-
Our clientele includes a mix of vaccine adjuvants market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe vaccine adjuvants market, including forecasts for subscribers. This continent databook contains high-level insights into Europe vaccine adjuvants market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe vaccine adjuvants market size, by country, 2021-2033 (US$M)
Europe Vaccine Adjuvants Market Share, 2025 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
